155 related articles for article (PubMed ID: 36484292)
1. Severe, life-threatening, and fatal chronic health conditions after allogeneic blood or marrow transplantation in childhood.
Holmqvist AS; Chen Y; Hageman L; Landier W; Wu J; Francisco LF; Ross ES; Balas NA; Bosworth A; Te HS; Goldman FD; Rosenthal J; Wong FL; Weisdorf DJ; Armenian SH; Bhatia S
Cancer; 2023 Feb; 129(4):624-633. PubMed ID: 36484292
[TBL] [Abstract][Full Text] [Related]
2. Burden of Long-Term Morbidity Borne by Survivors of Acute Myeloid Leukemia Treated With Blood or Marrow Transplantation: The Results of the BMT Survivor Study.
Armenian SH; Chen Y; Hageman L; Wu J; Landier W; Bosworth A; Francisco L; Schlichting E; Bhatia R; Salzman D; Wong FL; Weisdorf DJ; Forman SJ; Arora M; Bhatia S
J Clin Oncol; 2022 Oct; 40(28):3278-3288. PubMed ID: 35731989
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Late Mortality Risk After Allogeneic Blood or Marrow Transplantation Performed in Childhood.
Holmqvist AS; Chen Y; Wu J; Battles K; Bhatia R; Francisco L; Hageman L; Kung M; Ness E; Parman M; Salzman D; Wadhwa A; Winther JF; Rosenthal J; Forman SJ; Weisdorf DJ; Armenian SH; Arora M; Bhatia S
JAMA Oncol; 2018 Dec; 4(12):e182453. PubMed ID: 30054602
[TBL] [Abstract][Full Text] [Related]
4. Burden of Morbidity after Allogeneic Blood or Marrow Transplantation for Inborn Errors of Metabolism: A BMT Survivor Study Report.
Wadhwa A; Chen Y; Hageman L; Schlichting E; Funk E; Hicks J; Balas N; Siler A; Wu J; Francisco L; Holmqvist A; Gupta A; Lund T; Orchard PJ; Armenian S; Arora M; Bhatia S
Transplant Cell Ther; 2022 Mar; 28(3):157.e1-157.e9. PubMed ID: 34879288
[TBL] [Abstract][Full Text] [Related]
5. Late morbidity and mortality after autologous blood or marrow transplantation for lymphoma in children, adolescents and young adults-a BMTSS report.
Holmqvist AS; Meng Q; Dai C; Hageman L; Landier W; Wu J; Francisco LF; Ross ES; Balas N; Bosworth A; Te HS; Bhatia R; Rosenthal J; Wong FL; Weisdorf D; Armenian SH; Bhatia S
Leukemia; 2024 Mar; 38(3):601-609. PubMed ID: 38374408
[TBL] [Abstract][Full Text] [Related]
6. Comparison of transplant outcomes from matched sibling bone marrow or peripheral blood stem cell and unrelated cord blood in patients 50 years or older.
Konuma T; Tsukada N; Kanda J; Uchida N; Ohno Y; Miyakoshi S; Kanamori H; Hidaka M; Sakura T; Onizuka M; Kobayashi N; Sawa M; Eto T; Matsuhashi Y; Kato K; Ichinohe T; Atsuta Y; Miyamura K;
Am J Hematol; 2016 May; 91(5):E284-92. PubMed ID: 26910296
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome and late effects in patients transplanted with mobilised blood or bone marrow: a randomised trial.
Friedrichs B; Tichelli A; Bacigalupo A; Russell NH; Ruutu T; Shapira MY; Beksac M; Hasenclever D; Socié G; Schmitz N
Lancet Oncol; 2010 Apr; 11(4):331-8. PubMed ID: 20117965
[TBL] [Abstract][Full Text] [Related]
8. PBSCT is associated with poorer survival and increased chronic GvHD than BMT in Japanese paediatric patients with acute leukaemia and an HLA-matched sibling donor.
Shinzato A; Tabuchi K; Atsuta Y; Inoue M; Inagaki J; Yabe H; Koh K; Kato K; Ohta H; Kigasawa H; Kitoh T; Ogawa A; Takahashi Y; Sasahara Y; Kato S; Adachi S
Pediatr Blood Cancer; 2013 Sep; 60(9):1513-9. PubMed ID: 23512888
[TBL] [Abstract][Full Text] [Related]
9. Trends in Late Mortality and Life Expectancy After Allogeneic Blood or Marrow Transplantation Over 4 Decades: A Blood or Marrow Transplant Survivor Study Report.
Bhatia S; Dai C; Landier W; Hageman L; Wu J; Schlichting E; Siler A; Funk E; Hicks J; Bosworth A; Te HS; Francisco L; Bhatia R; Salzman D; Goldman FD; Forman SJ; Weisdorf DJ; Wong FL; Arora M; Armenian SH
JAMA Oncol; 2021 Nov; 7(11):1626-1634. PubMed ID: 34499078
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults.
Holtick U; Albrecht M; Chemnitz JM; Theurich S; Skoetz N; Scheid C; von Bergwelt-Baildon M
Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD010189. PubMed ID: 24748537
[TBL] [Abstract][Full Text] [Related]
11. Late mortality after bone marrow transplant for chronic myelogenous leukemia in the context of prior tyrosine kinase inhibitor exposure: A Blood or Marrow Transplant Survivor Study (BMTSS) report.
Wu J; Chen Y; Hageman L; Francisco L; Ness EC; Parman M; Kung M; Watson JA; Weisdorf DJ; Snyder DS; McGlave PB; Forman SJ; Arora M; Armenian SH; Bhatia R; Bhatia S
Cancer; 2019 Nov; 125(22):4033-4042. PubMed ID: 31412155
[TBL] [Abstract][Full Text] [Related]
12. Impact of stem cell source on allogeneic stem cell transplantation outcome in hematological malignancies.
Stamatović D; Balint B; Tukić L; Elez M; Tarabar O; Todorović M; Ostojić G; Tatomirovic Z; Ljubenov M; Marjanović S; Malesević M
Vojnosanit Pregl; 2011 Dec; 68(12):1026-32. PubMed ID: 22352263
[TBL] [Abstract][Full Text] [Related]
13. Comparisons between allogeneic peripheral blood stem cell transplantation and allogeneic bone marrow transplantation in adult hematologic disease: a single center experience.
Liu YC; Chang CS; Liu TC; Chen TP; Sue YC; Hsiao HH; Lin SF
Kaohsiung J Med Sci; 2003 Nov; 19(11):541-8. PubMed ID: 14658482
[TBL] [Abstract][Full Text] [Related]
14. Matched-pair analysis comparing allogeneic PBPCT and BMT from HLA-identical relatives in childhood acute lymphoblastic leukemia.
Vicent MG; Madero L; Ortega JJ; Martinez A; Gomez P; Verdeguer A; Badell I; Muñoz A; Olive T; Maldonado MS; Bureo E; Cubells J; Diaz MA;
Bone Marrow Transplant; 2002 Jul; 30(1):9-13. PubMed ID: 12105771
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic and immune recovery after allogeneic peripheral blood stem cell transplantation and bone marrow transplantation in a pediatric population.
Nagatoshi Y; Kawano Y; Watanabe T; Abe T; Okamoto Y; Kuroda Y; Takaue Y; Okamura J
Pediatr Transplant; 2002 Aug; 6(4):319-26. PubMed ID: 12234273
[TBL] [Abstract][Full Text] [Related]
16. Morbidity burden in survivors of multiple myeloma who underwent autologous transplantation: A Bone Marrow Transplantation Survivor Study.
Arora M; Chen Y; Hageman L; Wu J; Landier W; Francisco L; Kung M; Ness E; Bosworth A; Pamukcuoglu M; Weisdorf DJ; Forman SJ; Armenian SH; Bhatia S
Cancer; 2020 Jul; 126(14):3322-3329. PubMed ID: 32413187
[TBL] [Abstract][Full Text] [Related]
17. Relapsed acute lymphoblastic leukemia: similar outcomes for autologous and allogeneic marrow transplantation in selected children.
Parsons SK; Castellino SM; Lehmann LE; Eickhoff CE; Tarbell NJ; Sallan SE; Weinstein HJ; Billett AL
Bone Marrow Transplant; 1996 May; 17(5):763-8. PubMed ID: 8733695
[TBL] [Abstract][Full Text] [Related]
18. Children with acute leukemia: a comparison of outcomes from allogeneic blood stem cell and bone marrow transplantation.
Lin YF; Lairson DR; Chan W; Du XL; Leung KS; Kennedy-Nasser AA; Martinez CA; Heslop HE; Brenner MK; Krance RA
Pediatr Blood Cancer; 2011 Jan; 56(1):143-51. PubMed ID: 21108446
[TBL] [Abstract][Full Text] [Related]
19. Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial.
Flowers ME; Parker PM; Johnston LJ; Matos AV; Storer B; Bensinger WI; Storb R; Appelbaum FR; Forman SJ; Blume KG; Martin PJ
Blood; 2002 Jul; 100(2):415-9. PubMed ID: 12091330
[TBL] [Abstract][Full Text] [Related]
20. Improved disease-free-survival after transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical unrelated donors in patients with first chronic phase chronic myeloid leukemia.
Elmaagacli AH; Basoglu S; Peceny R; Trenschel R; Ottinger H; Lollert A; Runde V; Grosse-Wilde H; Beelen DW; Schaefer UW
Blood; 2002 Feb; 99(4):1130-5. PubMed ID: 11830457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
